Celyad Oncology (CYAD) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free CYAD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - April 4 at 2:12 AMCSBR Champions Oncology, Inc.seekingalpha.com - March 29 at 5:02 AMCelyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookfinanznachrichten.de - January 17 at 9:24 AMCelyad Oncology provides fourth quarter 2023 business update and 2024 outlookfinance.yahoo.com - January 16 at 7:20 PMCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)businesswire.com - December 17 at 7:27 AMCelyad Announces Management Changefinance.yahoo.com - December 4 at 9:32 AMInformation on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 Maytmcnet.com - November 14 at 8:33 PMCelyad Oncology Share Price (CYAD.BR)lse.co.uk - November 11 at 11:45 PMCelyad Oncology SA: Celyad Oncology reports third quarter 2023 financial results and recent business highlightsfinanznachrichten.de - November 9 at 8:15 AMCelyad Oncology reports third quarter 2023 financial results and recent business highlightsfinance.yahoo.com - November 9 at 1:35 AMCelyad Oncology SA: Celyad Oncology announces the termination of its American Depository Receipt programfinanznachrichten.de - September 26 at 10:39 AMCelyad Oncology to Terminate ADR Programmarketwatch.com - September 25 at 5:45 PMCelyad Oncology announces the termination of its American Depository Receipt programfinance.yahoo.com - September 25 at 5:45 PMCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCfinance.yahoo.com - September 15 at 7:50 PMCelyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SAbusinesswire.com - September 12 at 8:47 PMCelyad Oncology SA (CYAD.BR)ca.finance.yahoo.com - September 12 at 10:43 AMCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCfinance.yahoo.com - September 7 at 6:54 PMCelyad Oncology SA: Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - September 4 at 8:51 PMCelyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - September 4 at 8:51 PMCelyad Oncology (CYADY) Earnings Dates & Reportsinvesting.com - September 4 at 10:03 AMCelyad Oncology Receives Approximately EUR 9.8m in Private Placement Commitments From Historical Shareholdersfinance.yahoo.com - August 29 at 5:02 PMCelyad Oncology SA: Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersfinanznachrichten.de - August 25 at 9:07 AMCelyad Oncology SA (CYADY)investing.com - July 19 at 1:01 PMCelyad Oncology SA: Celyad Oncology announces receipt of Nasdaq delisting noticefinanznachrichten.de - May 16 at 8:37 AMCelyad Oncology Announces Receipt of Nasdaq Delisting Noticefinance.yahoo.com - May 15 at 6:38 PMCelyad plans to delist from Nasdaq amid cash woesmsn.com - May 5 at 10:10 AMCelyad Oncology reports first quarter 2023 financial results and recent business highlightsfinance.yahoo.com - May 5 at 1:16 AMCelyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaqfinance.yahoo.com - May 5 at 1:16 AMCelyad Oncology SA: Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid Pricefinanznachrichten.de - April 27 at 11:07 AMCelyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid Pricefinance.yahoo.com - April 24 at 6:43 PMCelyad Oncology announces receipt of Nasdaq noticefinance.yahoo.com - April 4 at 8:52 PMCelyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 27 at 10:16 AMCelyad Oncology Appoints Georges Rawadi As CEO - Quick Factsmarkets.businessinsider.com - March 24 at 3:36 AMCelyad Oncology Appoints Georges Rawadi as Its New CEOfinance.yahoo.com - March 24 at 3:36 AMCelyad Oncology SA: Celyad Oncology Reports Full Year 2022 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 23 at 5:11 PMCelyad Oncology reports full year 2022 financial results and recent business highlightsfinance.yahoo.com - March 23 at 5:11 PMCelyad Oncology to Announce Full Year 2022 Financial Results and Host Conference Callfinance.yahoo.com - March 17 at 6:54 PMCelyad slumps ~30% as board to put proposal to continue activities on vote at shareholders' meetmsn.com - March 15 at 9:02 AMCelyad Oncology announces non-cash impairmentfinance.yahoo.com - March 15 at 4:01 AMCelyad Oncology: Letter to Shareholdersfinance.yahoo.com - March 1 at 10:19 AMREPEAT -- Celyad Oncology SA - Letter to Shareholdersfinance.yahoo.com - March 1 at 10:19 AMCelyad Oncology SA - Letter to Shareholdersfinance.yahoo.com - February 28 at 1:41 PMCelyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01finance.yahoo.com - February 9 at 1:58 AMCelyad Oncology provides fourth quarter 2022 business update and 2023 outlookuk.finance.yahoo.com - February 3 at 1:10 AMCelyad Oncology SA (CYAD)ca.finance.yahoo.com - January 18 at 5:10 PMThinking about buying stock in Celyad Oncology, Calyxt, IQIYI, Vinco Ventures, or Carvana?benzinga.com - January 17 at 12:45 PMmarketbeat.com - January 17 at 9:50 AMCelyad Oncology Completely Shifts To Preclinical Stage, Pulls Plug On Only Human Trial Assetfinance.yahoo.com - December 29 at 4:30 AMCelyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harnesstmcnet.com - December 21 at 7:27 AMCelyad Oncology To Discontinue CYAD-211 Clinical Program In Multiple Myelomamarkets.businessinsider.com - December 21 at 7:27 AM Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. CYAD Media Mentions By Week CYAD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYAD News Sentiment▼0.000.32▲Average Medical News Sentiment CYAD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYAD Articles This Week▼00▲CYAD Articles Average Week Get Celyad Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cocrystal Pharma News Talphera News Kiora Pharmaceuticals News Aytu BioPharma News NeuroBo Pharmaceuticals News VBI Vaccines News Edesa Biotech News ABVC BioPharma News Minerva Neurosciences News Benitec Biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYAD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celyad Oncology SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
